Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148 JPY | -2.63% | +2.78% | -10.30% |
Apr. 10 | Healios Partners with AND Medical Group; Set to Receive Upfront Payment of 60 Million Yen | MT |
Apr. 09 | Healios K.K. Enters into Joint Research Agreement with AND Medical Group | CI |
Sales 2024 * | 910M 5.85M | Sales 2025 * | 1.38B 8.85M | Capitalization | 13.34B 85.77M |
---|---|---|---|---|---|
Net income 2024 * | -2.69B -17.31M | Net income 2025 * | -2.41B -15.52M | EV / Sales 2024 * | 13.8 x |
Net cash position 2024 * | 822M 5.29M | Net Debt 2025 * | 608M 3.91M | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-4.46
x | P/E ratio 2025 * |
-4.84
x | Employees | 64 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.62% |
1 day | -2.63% | ||
1 week | +2.78% | ||
Current month | -8.07% | ||
1 month | -1.99% | ||
3 months | -5.73% | ||
6 months | -7.50% | ||
Current year | -10.30% |
Managers | Title | Age | Since |
---|---|---|---|
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 11-02-23 |
Richard Kincaid
DFI | Director of Finance/CFO | 47 | 18-02-28 |
Masanori Sawada
CTO | Chief Tech/Sci/R&D Officer | 42 | 12-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 12-12-31 | |
Director/Board Member | 71 | 18-02-28 | |
Hardy Kagimoto
CEO | Chief Executive Officer | 47 | 11-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 148 | -2.63% | 437 500 |
24-04-24 | 152 | -0.65% | 511,900 |
24-04-23 | 153 | +4.79% | 1,341,200 |
24-04-22 | 146 | +0.69% | 455,400 |
24-04-19 | 145 | 0.00% | 1,321,400 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.30% | 88.35M | |
-2.05% | 104B | |
+1.92% | 97.42B | |
+0.79% | 22.2B | |
-17.71% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-15.77% | 15.06B | |
+3.95% | 13.98B | |
+35.04% | 11.66B |
- Stock Market
- Equities
- 4593 Stock